Sorted By:

Relevance


Medicare Monday: A guide to MedPAC’s Part B vote this week

PhRMA  |  Blog Post

Keep an eye on MedPAC activity later this week to see what happens with these draft recommendations.
http://catalyst.phrma.org/medicare-monday-a-guide-to-medpacs-part-b-vote-this-week

She Has Health Insurance, But Can't Pay Her Medical Bills. She's Not Alone.

Access Better Coverage  |  From Our Network

Instead, she says, she's now overwhelmed with medical bills.
http://www.accessbettercoverage.org/social-news/she-has-health-insurance-but-cant-pay-her-medical-bills

ICYMI: Wall Street Journal and Washington Post Say TPP Should Protect Medical Innovation

PhRMA  |  Blog Post

In case you missed it, .wsj.com/articles/pacific-trade-brinksmanship-1438904177" target="_blank"...
http://catalyst.phrma.org/icymi-wsj-and-washington-post-say-tpp-should-protect-medical-innovation

Better Use of Medicines Yields Significant Health Gains by Avoiding the Need for Other Medical Services

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-6/better-use-of-medicines-yields-significant-health-gains-by-avoiding-the-need-for-other-medical-services

Exchanges State Map

PhRMA  |  From PhRMA

State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state through the following actions: Enforcing non-discrimination requirements, which app...
https://www.phrma.org/media/exchanges-state-map

Join PhRMA

PhRMA  |  From PhRMA

MEMBERSHIP QUALIFICATIONS A corporation, subsidiary or division of a company with operations in the United States that is predominantly engaged in the research, manufacturing and marketing of innovative finished dosage prescription pharmaceutical or biological medicines...
https://www.phrma.org/media/join-phrma

PhRMA: Propuesta de Clinton Volvería Atrás el Reloj en la Innovación Médica

PhRMA  |  Press Release

• Detendría la innovación médica y enfriaría la  inversión en Investigación y Desarrollo mediante la reducción de la protección de datos para los productos biológicos.
https://www.phrma.org/press-release/phrma-propuesta-de-clinton-volver-a-atr-s-el-reloj-en-la-innovaci-n-m-dica

PhRMA Statement on Proposal for an Alternative Approval Pathway for Certain Drugs Intended to Address Unmet Medical Need

PhRMA  |  Press Release

We have long supported FDA’s appropriate use of innovative approaches and regulatory flexibility when considering the type and quantity of data required to establish the safety and efficacy of these medicines—as well as other innovative medicines to address unmet medical needs. 
https://www.phrma.org/press-release/phrma-statement-on-proposal-for-an-alternative-approval-pathway-for-certain-drugs-intended-to-address-unmet-medical-need

PhRMA Statement on Industry Support of Medical Education

PhRMA  |  Press Release

“Still, to safeguard against even the perception of a conflict of interest, medical societies and others already have drafted robust codes of conduct.
https://www.phrma.org/press-release/phrma-statement-on-industry-support-of-medical-education

Director – Public Affairs

PhRMA  |  PhRMA Career

We offer traditional (medical, dental, vision, flexible spending, life, AD&D, LTD, STD, LTC) and enhanced benefits such as parental leave, health advocate service, back-up childcare, commuting and financial & estate planning benefits.
https://www.phrma.org/careers/director-public-affairs

Medicare Monday: Putting MedPAC’s 19% in context

PhRMA  |  Blog Post

Eighty-one percent ($465 billion) of all Medicare spending goes toward hospital care, skilled nursing facilities, hospice, surgery, lab tests, physician visits and more.
http://catalyst.phrma.org/medicare-monday-putting-medpac-s-19-in-context

Spurring Innovation in Rare Diseases

PhRMA  |  Fact Sheet

While the median number of patients with each rare disease is less than 10,000, rare diseases affect 30 million Americans – about 1 in 10.
https://www.phrma.org/fact-sheet/spurring-innovation-in-rare-diseases

The Value of Cancer Treatment Today

PhRMA  |  From PhRMA

In recent decades, tremendous progress has been made in the fight against cancer. Continued research has expanded our knowledge of how the disease develops and how to target medicines for specific cancer types – resulting in more effective therapies for patients. Biopharmaceutical companies are d...
https://www.phrma.org/media/the-value-of-cancer-treatment-today

Patients Facing Access Restrictions Incur Greater Medical Spending

Chartpack  |  From Our Network

Non-elderly Medicaid patients facing formulary restrictions for antipsychotic medications were more likely to be hospitalized and had higher medical costs than patients in states without formulary restrictions.
http://chartpack.phrma.org/biophrma-chartpack/outcomes-and-savings/patients-facing-access-restrictions-incur-greater-medical-spending

The Pacira Case Study: Patients are better served when health care professionals have the most accurate and up-to-date medical information

PhRMA  |  Blog Post

Patients are better served when health care professionals have the most accurate and up-to-date medical information.
http://catalyst.phrma.org/the-pacira-case-study-patients-are-better-served-when-health-care-professionals-have-the-most-accurate-and-up-to-date-medical-information

Subjecting Prescription Drugs to a Combined Deductible Results in Disproportionately High Cost Sharing for Drugs Compared to Other Types of Medical Care

Chartpack  |  From Our Network

An analysis of the most common type of exchange plans under the Affordable Care Act found that drug coverage was generally less generous than for other covered services—primarily because plans subjected drug spending to a large deductible....
http://chartpack.phrma.org/biophrma-chartpack/spending-and-costs/subjecting-prescription-drugs-to-a-combined-deductible-results-in-disproportionately-high-cost-sharing-for-drugs-compared-to-other-types-of-medical-care

PhRMA Recognizes 2016 Research & Hope Award Recipients

PhRMA  |  From PhRMA

“The Lupus Foundation of America has established a national medical research program that is based on establishing smarter research to achieve faster progress.
https://www.phrma.org/media/phrma-recognizes-2016-research-and-hope-award-recipients

ICYMI: More Evidence That Increased Use of Medicines Helps Reduce Spending on Other Medical Care

PhRMA  |  Blog Post

“The current findings suggest that a five percent increase in the use of antihypertensive medication by patients with those two conditions [hypertension and high cholesterol] may prompt reductions in medical (Parts A and B) costs of more than $800 annually per beneficiary,” according to the report.
http://catalyst.phrma.org/icymi-more-evidence-that-increased-use-of-medicines-helps-reduce-spending-on-other-medical-care

Insurance Covers a Lower Share of Prescription Drug Costs Than of Other Medical Services

Chartpack  |  From Our Network

Insurance covers a lower share of prescription medicine costs than of other medical services, like hospital care.
http://chartpack.phrma.org/biophrma-chartpack/spending-and-costs/insurance-covers-a-lower-share-of-prescription-drug-costs-than-of-other-medical-services

Are Health Insurance Exchange Cost-Sharing Reductions Really Helping Low-Income Patients Access Medicines?

PhRMA  |  Blog Post

Ensuring that patients have access to the medicines they need is at the heart of what biopharmaceutical research companies do every day. The Affordable Care Act put in place a new way for Americans to access health insurance coverage and even provides assistance in ...
http://catalyst.phrma.org/are-health-insurance-exchange-cost-sharing-reductions-really-helping-low-income-patients-access-medi

New Report Shows Clinical Trials in Piedmont Triad Region Benefit Local Patients, Economy and Medical Science

PhRMA  |  Press Release

Forsyth Medical Center, Winston-Salem. 
https://www.phrma.org/press-release/new-report-shows-clinical-trials-in-piedmont-triad-region-benefit-local-patients-economy-and-medical-science

Special Edition Medicare Monday: More context on MedPAC’s analysis of drug costs

PhRMA  |  Blog Post

These comparisons aren’t included in MedPAC’s presentation, but should be used to help put the presentation’s findings in context.
http://catalyst.phrma.org/special-edition-medicare-monday-more-context-on-medpac-s-analysis-of-drug-costs

Medicare Monday: Billing code basics for biologics in Part B

PhRMA  |  Blog Post

MedPAC is currently considering a proposal that would change this system.
http://catalyst.phrma.org/medicare-monday-billing-code-basics-biologics-part-b

Let's Talk About Cost

PhRMA  |  From PhRMA


https://www.phrma.org/advocacy/cost-and-value

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

PhRMA  |  Press Release

Dear Secretary Laboy Rivera: On behalf of our members, PhRMA wants to thank you for your leadership in the recovery efforts in Puerto Rico after two recent hurricanes – most notably Hurricane Maria – struck the island last month.
https://www.phrma.org/press-release/phrma-letter-to-puerto-rico-secretary-of-economic-development-and-commerce

You have reviewed the first 100 results out of 1046. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next